...
首页> 外文期刊>Journal of Medical Case Reports >Reduced cystatin C-estimated GFR and increased creatinine-estimated GFR in comparison with iohexol-estimated GFR in a hyperthyroid patient: A case report
【24h】

Reduced cystatin C-estimated GFR and increased creatinine-estimated GFR in comparison with iohexol-estimated GFR in a hyperthyroid patient: A case report

机译:甲状腺功能亢进患者的胱抑素C估计GFR降低和肌酐估计GFR升高(与碘海醇估计GFR相比):一例

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction Estimation of the glomerular filtration rate (GFR) is essential for the evaluation of patients with kidney disease, and for treating patients with drugs that are eliminated from the circulation by the kidneys. Cystatin C has been shown to be superior to creatinine for estimating GFR in several studies. However, studies showing that thyroid function has an impact on cystatin C have not addressed the question of whether the changes in cystatin C levels are due to changes in GFR or in cystatin C synthesis. Case presentation We report an account of a hyperthyroid patient with a discrepancy between the GFR estimates from cystatin C and creatinine. The cystatin C concentration (1.36 mg/L) was higher and gave an estimated GFR which was lower (51 mL/min/1.73 m2), while the creatinine concentration was lower (36 μmol/L) and gave a corresponding creatinine-estimated GFR that was higher (145 mL/min/1.73 m2) than the iohexol-estimated GFR (121 mL/min/1.73 m2) during the hyperthyroid period. After thyroidectomy, the creatinine concentration was 36 μmol/L and creatinine-estimated GFR was calculated as 73 mL/min/1.73 m2, while the cystatin C concentration and cystatin C-calculated GFR was 0.78 mg/L and 114 mL/min/1.73 m2, respectively. Conclusion In contrast to creatinine, cystatin C levels rose in the hyperthyroid state as compared to the euthyroid state. The cystatin C-estimated GFR was reduced compared to the iohexol-estimated GFR. This patient case shows that the hyperthyroid-associated changes in cystatin C levels are not due to changes in GFR. Thyroid function should thus be considered when both cystatin C and creatinine are used as markers of kidney function.
机译:简介肾小球滤过率(GFR)的估计对于评估肾病患者和使用经肾脏排除的药物治疗患者至关重要。在一些研究中,胱抑素C在估计GFR方面优于肌酐。然而,研究表明甲状腺功能对半胱氨酸蛋白酶抑制剂C有影响,但尚未解决半胱氨酸蛋白酶抑制剂C水平变化是由于GFR的变化还是半胱氨酸蛋白酶抑制剂C合成变化的问题。病例介绍我们报告了一个甲状腺功能亢进患者的报告,该患者的半胱氨酸蛋白酶抑制剂C和肌酐的GFR估算值存在差异。半胱氨酸蛋白酶抑制剂C的浓度(1.36 mg / L)较高,估计的GFR较低(51 mL / min / 1.73 m2),而肌酐的浓度较低(36μmol/ L),并具有相应的肌酐估计的GFR在甲状腺功能亢进期,这比碘海醇估计的GFR(121 mL / min / 1.73 m2)高(145 mL / min / 1.73 m2)。甲状腺切除后,肌酐浓度为36μmol/ L,肌酐估算的GFR为73 mL / min / 1.73 m2,胱抑素C浓度和胱抑素C计算的GFR为0.78 mg / L和114 mL / min / 1.73分别为结论与肌酐相比,甲状腺功能亢进状态的胱抑素C水平高于正常甲状腺状态。与碘海醇估计的GFR相比,胱抑素C估计的GFR降低。该患者病例显示半胱氨酸蛋白酶抑制剂C水平与甲状腺功能亢进有关的变化不是由于GFR的变化所致。因此,当将胱抑素C和肌酐同时用作肾脏功能的标志物时,应考虑甲状腺功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号